Ocugen Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$1.06

+0.03 (+2.91%)

As of Sep 20, 10:27 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +2,727.4% upside

Low Target $22.68

Average Target $29.97

High Target $39.58

Current Price $1.06

Current
$1.06

Target
$29.97

$22.68 $29.97 avg $39.58

Scenario Analysis

Bear Case

$22.68

2,039.6%

Low target

Base Case

$29.97

+2,727.4%

Avg target

Bull Case

$39.58

+3,634.0%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$2.73

-61.1% from high

52-Week Low

$0.97

+9.3% from low

Target vs 52W High

$29.97

+999.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.8%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-15.1%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-17.9%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.2%